SEARCH

SEARCH BY CITATION

References

  • Adamczak M, Charubin D, Bednarski WI. 2009. Influence of reaction medium composition on enzymatic synthesis of galactooligosaccharides and lactulose from lactose concentrates prepared from whey permeate. Chem Papers 63(2):1116.
  • Akiyama K, Takase M, Horikoshi K, Okonogi S. 2001. Production of galactooligosaccharides from lactose using a β-glucosidase from Thermus sp. Z-1. Biosci Biotechnol Biochem 65:43841.
  • Albayrak N, Yang ST. 2002. Production of galacto-oligosaccharides from lactose by Aspergillus oryzae β-galactosidase immobilized on cotton cloth. Biotechnol Bioeng 77:819.
  • Alliet P, Scholtens P, Raes M, Hensen K, Jongen H, Rummens JL, Boehm G, Vandenplas Y. 2007. Effect of prebiotic galacto-oligosaccharide, long-chain fructo-oligosaccharide infant formula on serum cholesterol and triacylglycerol levels. Nutrition 23(10):71923.
  • Ben XM, Li J, Feng ZT, Shi SY, Lu YD, Chen R, Zhou XY. 2008. Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli. World J Gastroenterol 14(42):65648.
  • Boehm G, Stahl B, Jeline kJ, Knol J, Miniello V, Moro GE. 2005. Prebiotic carbohydrates in human milk and formulas. Acta Paediatrica. 94 (Suppl 449):1821.
  • Broek LAMVD, Hinz SWA, Beldman G, Vincken JP, Voragen AGJ. 2008. Bifidobacterium carbohydrases-their role in breakdown and synthesis of (potential) prebiotics. Mol Nutr Food Res 52(1):14663.
  • Bruins ME, Strubel M, van Lieshout JFT, Janssen AEM, Boom RM. 2003.Oligosaccharide synthesis by the hyperthermostable b-glucosidase from Pyrococcus furiosus: kinetics and modelling. Enzyme Microb Technol 33:311.
  • Bruzzese E, Volpicelli M, Squaglia M, Tartaglione A, Guarino A. 2006. Impact of prebiotics on human health. Dig Liver Dis 38:S2837.
  • Cho YJ, Shin HJ, Bucke C. 2003. Purification and biochemical properties of a galactooligosaccharides producing β-Galactosidase from Bullera singularis. Biotech Let 25:2107211.
  • Chockchaisawasdee S, Athanasopoulos VI, Niranjan K, Rastall RA. 2005. Synthesis of galacto-oligosaccharide from lactose using β-galactosidase from Kluyveromyces lactis: studies on batch and continuous UF membrane-fitted bioreactors. Biotech Bioengineer 89(4):43443.
  • Chonan O, Takahashi R, Watanuki M. 2001. Role of activity of gastrointestinal microbiotia in absorption of calcium and magnesium in rats fed beta 1–4 linked galactooligosaccharides. Biosci Biotechnol Biochem 65:18725.
  • Cummings JH, Macfarlane GT, Macfarlane S. 2003. Intestinal bacteria and ulcerative colitis. Curr Issues Intest Microbial 4(1):920.
  • Curda L, Rudolfova J, Stetina J, Dryak B. 2006. Dried buttermilk containing galactooligosaccharides: process layout and its verification. J Food Eng 77:46871.
  • Davis LMG, Martínez I, Walter J, Hutkins R. 2010. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int J Food Microbiol 144:28592.
  • Depeint F, Tzortzis G, Vulevic J, I’Anson K, Gibson GR. 2008. Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. Am J Clin Nutr 87:78591.
  • Dokkum WV, Wexendonk B, Srikumar TS, Van Den Heuval EG. 1999. Effect of nondigestible oligosaccharides on large bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr 53: 17.
  • D'souza A, Fordjour L, Ahmad A, Cai C, Kumar D, Valencia G, Aranda JV, Beharry KD. 2010. Effects of probiotics, prebiotics, and synbiotics on messenger RNA expression of caveolin-1, NOS, and genes regulating oxidative stress in the terminal ileum of formula-fed neonatal rats. Pediatr Res 67:52631.
  • Fanaro S, Marten B, Bagna R, Vigi V, Fabris C, Pena-Quintana L, Arguelles F, Scholz-Ahrens KE, Sawatzki G, Zelenka R, Schrezenmeir J, de Vrese M, Bertino E. 2009. Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study. J Pediatr Gastroenterol Nutr 48:828.
  • Garssen J, Arsnalognu S, Boehm G, Moro G, Faber J, Knol E, Ruiter B, Hoffen E, Willemsen L, M’Rabet L, Knippels LMJ. 2007. A specific mixture of short chain galacto-oligosaccharides and long chain fructo-oligosaccharides induces an anti-allergic immunoglobulin profile in infants at risk for allergy. World Allergy Organ J S1267.
  • Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB.2004. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17:25975.
  • Gosling A, Stevens GW, Barber AR, Kentish SE, Gras SL.2010. Recent advances refining galactooligosaccharide production from lactose. Food Chem 121:30718.
  • Goulas A, Tzortzis G, Gibson GR. 2007. Development of a process for the production and purification of α- and β-galactooligosaccharides from Bifidobacterium bifidum NCIMB 41171. Int Dairy J 17:64856.
  • Haarman M, Knol J. 2005. Quantitative real-time PCR assays to identify and quantify fecal bifidobacterium species in infants receiving a prebiotic infant formula. Applied Environ Microbiol 71(5):231824.
  • Heavey PM, Savage SA, Parrett A, Cecchini C, Edwards CA, Rowland IR. 2003. Protein-degradation products and bacterial enzyme activities in faeces of breast-fed and formula-fed infants. Br J Nutr 89:50915.
  • Hellerova K, Curda L. 2009. Influence of type of substrate and enzyme concentration on formation of galacto-oligosaccharides. Czech J Food Sci 27:S3724.
  • Hoffen EV, Ruiter B, Faber J, M’Rabet L, Knol EF, Stahl B, Arslanoglu S, Moro G, Boehm G, Garssen J. 2009. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 64(3):4847.
  • Holma R, Juvonen P, Asmawi MZ, Vapaatalo H, Korpela R. 2002. Galactooligosaccharides stimulate the growth of bifidobacteria but fail to attenuate inflammation in experimental colitis in rats. Scand J Gastroenterol 37(9):10427.
  • Hopkins MJ, Macfarlane GT. 2003. Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Appl Environ Microbiol 69:19207.
  • Hsu CA, Lee SL, Chou CC. 2007. Enzymatic production of galactooligosaccharides by beta-galactosidase from Bifidobacterium longum BCRC 15708. J Agric Food Chem 55(6):222530.
  • Inan MS, Rasoulpour RJ, Yin L, Hubbard AK, Rosenberg DW, Giardina C. 2000. The luminal short-chain fatty acid butyrate modulates NF-jB activity in a human colonic epithelial cell line. Gastroenterology 118:72434.
  • Ji ES, Park NH, Oh DK. 2005. Galacto-oligosaccharide production by a thermostable recombinant β-galactosidase from Thermotoga maritima. World J Microbiol Biotechnol 21:75964
  • Kelly D, Conway S, Aminov R. 2005. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol 26:32633.
  • Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Turre T, Kuitunen M. 2007. Probiotics and prebiotic galactooligosaccharides in the prevention of allergic disease: a randomised, double blind, placebo- controlled trial. J Allerg Clin Immunol 119:1928.
  • Lee SY, Choi JH, Xu Z. 2003. Microbial cell-surface display. Trends Biotechnol 21:4552.
  • Leforestier G, Blais A, Blachier F, Baglieri AM, Gay AMD, Perrin E, Tome D. 2009. Effects of galacto-oligosaccharide ingestion on the mucosa-associated mucins and sucrase activity in the small intestine of mice. Eur J Nutr 48:45764.
  • Li Y, Lu L, Wang H, Xu X, Xiao M. 2009. Cell surface engineering of a β-galactosidase for galactooligosaccharide synthesis. Appl Environ Microbiol 593842.
  • Lomer MCE, Parkes GC, Sanderson JD. 2008. Review article: lactose intolerance in clinical practice: myths and realities. Aliment Pharmacol Ther 27(2):93103.
  • Lu LL, Xiao M, Li ZY, Li YM, Wang FS. 2009. A novel transglycosylating beta-galactosidase from Enterobacter cloacae B5. Process Biochem 44(2):2326.
  • Macfarlane GT, Steed H, Macfarlane S. 2008. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol 104:30544.
  • Macfarlane S, Furrie E, Cummings JH, Macfarlane GT. 2004. Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin Infect Dis 38:16909.
  • Manera AP, de Almeida Costa FA, Rodrigues MI, Kalil SJ, Filho FM. 2010. Galacto-oligosaccharides production using permeabilized cells of Kluyveromyces marxianus. Int J Food Engineer 6(4)113.
  • Martinez-Villaluenga C, Cardelle-Cobas A, Corzo N, Olano A, Villamiel M. 2007. Synthesis of galactooligosaccharides with prebiotic potential during hydrolysis of lactose by Lactozym 3000L HP G. Proceedings of the Nutrition Society 67(OCE):E54.
  • Mcbain AJ, Macfarlane GT. 2001. Modulation of genotoxic enzyme activities by non-digestible oligosaccharide metabolism in in-vitro human gut bacterial ecosystems. J Med Microbiol 50:83342.
  • Menrad K. 2003. Market and marketing of functional food in Europe. J Food Eng 56(2–3):1818.
  • Moro GE, Arslanoglu S, Stahl B, Jelinek U, Wahn U, Boehm G. 2006. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 91:8149.
  • Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS.2005. Human milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 135:13047.
  • Nauta AJ, Arsnalognu S, Boehm G, Moro G, Faber J, Knol E, Ruiter B, van Hoffen E, Rabet LM, Garssen J. 2008. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induced an anti-allergic Ig profile in infants at risk for allergy. Proc Nutr Soc 67 (OCE):E82.
  • Neri DFM, Balcao VM, Carneiro-da-Cunha MG, Carvalho LB Jr, Teixeira JA. 2008. Immobilization of β-galactosidase from Kluyveromyces lactis onto a polysiloxane-polyvinyl alcohol magnetic (mPOS-PVA) composite for lactose hydrolysis. Catalysis Comm 9:23349.
  • Neri DFM, Balcao VM, Costa RS, Rocha I, Ferreira E, Torres DPM. 2009. Galacto-oligosaccharides production during lactose hydrolysis by free Aspergillus oryzae beta galactosidase and immobilized on magnetic polysiloxane-polyvinyl alcohol. Food Chem 115(1):929.
  • Newburg DS, Ruiz-Palacios GM, Morrow AL.2005. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 25:3758.
  • Nurmi J, Puolakkainen P, Rautonen N.2005. Bifidobacterium lactis spp. 420 up-regulates cylooxygenase (Cox) 1 and down-regulates COX-2 gene expression in a Caco-2 cell culture model. Nutr Can 51:8392.
  • Onishi N, Yokozeki K. 1996. Gluco-oligosaccharide and galactooligosaccharides production by Rhodotorula minuta IFO879. J Ferment Bioeng 82:1247.
  • Park HY, Kim HJ, Lee JK, Kim D, Oh DK. 2008. Galactooligosaccharide production by a thermostable beta-galactosidase from Sulfolobus solfataricus. World J Microbiol Biotechnol 24(8):15538.
  • Placier G, Watzlawick H, Rabiller C, Mattes R. 2009. Evolved β-galactosidases from geobacillus stearothermophilus with improved transgalactosylation yield for galacto-oligosaccharide production. Appl Environ Microbiol 75(19):631221.
  • Roller M, Rechkemmer G, Watzl B. 2004. Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune function in rats. J Nutr 134:1536.
  • Roos YH. 2009. Solid and liquid states of lactose. In: McSweeneyPLH, FoxPF, editors. Lactose, water, salts and minor constituents. 3rd ed. New York : Springer. 1733.
  • Rowland IR, Rumney CJ, Coutts JT, Lievense L. 1998. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen induced aberrant crypt foci in rats. Carcinogenesis 2:2815.
  • Sazawal S, Dhingra U, Sarkar A, Dhingra A, Deb S, Marwah D, Menon VP, Black RE. 2004. Efficacy of milk fortified with a probiotic Bifidobacterium lactis HN019 (DR-10TM) and prebiotic galacto-oligosaccharides in prevention of morbidity: a community based double masked randomized trial. Pediatr Gastroenterol Hepatol Nutr 3714.
  • Schaafsma G. 2008. Lactose and lactose derivatives as bioactive ingredients in human nutrition. Int Dairy J 18:45865.
  • Scheppach W, Weiler F. 2004. The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care 7:5637.
  • Scholtens PAMJ, Alliet P, Raes M, Alles MS, Kroes H, Boehm G, Knippels LMJ, Knol J, Vandenplas Y. 2008. Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo oligosaccharides. J Nutr 138:11417.
  • Schwab C, Ganzle M. 2011. Lactic acid bacteria fermentation of human milk oligosaccharide components, human milk oligosaccharides and galactooligosaccharides. FEMS Microbiol Lett 315(2):1418.
  • Searle LEJ, Best A, Nunez A, Salguero FJ, Johnson L, Weyer U, Dugdale AH, Cooley WA, Carter B, Jones G, Tzortzis G, Woodward MJ, Ragione RML. 2009. A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice. J Med Microbiol 58:3748.
  • Sears P, Wong CH. 2001. Toward automated synthesis of oligosaccharides and glycoproteins. Science 291:234450.
  • Shoaf K, Mulvey GL, Armstrong GD, Hutkins RW. 2006. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect Immun 74:69208.
  • Splechtna B, Nguyen TH, Steinbock M, Kulbe KD, Lorenz W, Haltrich D. 2006. Production of prebiotic galacto-oligosaccharides from lactose using beta-galactosidases from Lactobacillus reuteri. J Agri Food Chem 54(14):49995006.
  • Torres DPM, Goncalves MPF, Teixeira JA, Rodrigues LR. 2010. Galacto-oligosaccharides: production, properties, applications, and significance as prebiotics. Compr Rev Food Sci Food Saf 9:43854.
  • Tzortzis G, Goulas AK, Gibson GR. 2005. Synthesis of prebiotic galactooligosaccharides using whole cells of a novel strain, Bifidobacterium bifidum NCIMB 41171. Appl Microbiol Biotechnol 68:4126.
  • van Dokkum W, Wezendonk B, Srikumar TS, Van Den Heuvel EG. 1999. Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr 18(53):17.
  • Veereman-Wauters G. 2005. Application of prebiotics in infant foods. Br J Nutr 93 (Suppl 1):S57S60.
  • Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. 2008. Modulation of fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 88(5):143846.
  • Wijnands MVW, Schoterman HC, Bruijntjes JP, Hollanders VMH, Woutersen RA. 2001. Effect of dietary galacto-oligosaccharides on azoxymethane-induced aberrant crypt foci and colorectal cancer in Fischer 344 rats. Carcinogenesis 22:12732.
  • Xiao-ming B, Xiao-yu Z, Wei-hua Z, Wen-liang Y, Wei P, Wei-li Z, Sheng-mei W, Beusekom CMV, Schaafsma A. 2004. Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants. Chin Med J 117:92731.
  • Zheng P, Yu H, Sun Z, Ni Y, Zhang W, Fan Y, Xu Y. 2006. Production of galacto-oligosaccharides by immobilized recombinant β-galactosidase from Aspergillus candidus. Biotechnol J 1:146470. Available from: http://www.vivinalgos.com/ (Health Canada website:http://hc-sc.gc.ca).